Tumor Necrosis Factor: What Is in a Name?

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• Tumor Necrosis Factor (TNF) is a cytokine initially identified for its cytotoxic effects on tumors.
• Research indicates TNF primarily acts as a proinflammatory cytokine, presenting challenges for direct cancer therapy.
• The pursuit of a single cytokine treatment for solid tumors and lymphomas continues.

Purpose of the Study:

• To review the historical research on TNF's anti-cancer properties.
• To discuss the dual role of TNF as both cytotoxic and proinflammatory.
• To explore the current status of TNF-based cancer treatment research.

Main Methods:

• Literature review of experimental studies on TNF.
• Analysis of historical and current research findings.
• Synthesis of information on TNF's biological activities and therapeutic applications.

Main Results:

• Early studies highlighted TNF's significant tumor-necrotizing potential.
• Subsequent research revealed TNF's predominant proinflammatory functions.
• The therapeutic application of TNF for cancer remains an active area of investigation.

Conclusions:

• TNF possesses a complex biological profile with both cytotoxic and proinflammatory activities.
• Despite initial promise, TNF's clinical application in cancer therapy is hindered by its inflammatory effects.
• Ongoing research aims to harness TNF's anti-tumor capabilities while mitigating its adverse inflammatory responses.